These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35789302)

  • 61. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre.
    Alzahrani N; Ung L; Valle SJ; Liauw W; Morris DL
    ANZ J Surg; 2017 Nov; 87(11):E167-E172. PubMed ID: 26178318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk factors for peritoneal dissemination of gastric cancer.
    Yeldan E; Oguz S; Usta U; Ilhan E; Senlikci A
    Minerva Chir; 2015 Apr; 70(2):91-6. PubMed ID: 25815699
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis.
    Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I;
    Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of long-term oncological outcomes of appendiceal cancer and colon cancer: A multicenter retrospective study.
    Son IT; Ahn S; Park KJ; Oh JH; Jeong SY; Park HC; Heo SC; Youk EG; Park JT; Ihn MH; Oh HK; Kim DW; Lee KH; Kang SB;
    Surg Oncol; 2016 Mar; 25(1):37-43. PubMed ID: 26979639
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer.
    Vogel P; Rüschoff J; Kümmel S; Zirngibl H; Hofstädter F; Hohenberger W; Jauch KW
    Dis Colon Rectum; 2000 Jan; 43(1):92-100. PubMed ID: 10813130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
    Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial.
    Bastiaenen VP; Klaver CEL; Kok NFM; de Wilt JHW; de Hingh IHJT; Aalbers AGJ; Boerma D; Bremers AJA; Burger JWA; van Duyn EB; Evers P; van Grevenstein WMU; Hemmer PHJ; Madsen EVE; Snaebjornsson P; Tuynman JB; Wiezer MJ; Dijkgraaf MGW; van der Bilt JDW; Tanis PJ
    BMC Cancer; 2019 Mar; 19(1):254. PubMed ID: 30898098
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [TBL] [Abstract][Full Text] [Related]  

  • 70. pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited.
    Snaebjornsson P; Coupe VM; Jonasson L; Meijer GA; van Grieken NC; Jonasson JG
    Int J Cancer; 2014 Jul; 135(2):467-78. PubMed ID: 24347179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reply to: Peritoneal invasion and metachronous peritoneal metastases after colon cancer surgery: The role of homogeneous, reliable assessment and confounders.
    Bastiaenen VP; Tanis PJ
    Eur J Surg Oncol; 2021 Oct; 47(10):2698-2699. PubMed ID: 34238641
    [No Abstract]   [Full Text] [Related]  

  • 72. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases.
    Sammartino P; Sibio S; Biacchi D; Cardi M; Mingazzini P; Rosati MS; Cornali T; Sollazzo B; Atta JM; Di Giorgio A
    Int J Colorectal Dis; 2014 Sep; 29(9):1081-9. PubMed ID: 24980687
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study.
    Kus T; Kose F; Aktas G; Arslan UY; Sedef AM; Cinkir HY; Dirikoc M; Akkus G; Ozdemir NY
    J Gastrointest Cancer; 2021 Jun; 52(2):634-642. PubMed ID: 32578034
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
    Cheong C; Shin JS; Suh KW
    World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
    Klaver CEL; Wisselink DD; Punt CJA; Snaebjornsson P; Crezee J; Aalbers AGJ; Brandt A; Bremers AJA; Burger JWA; Fabry HFJ; Ferenschild F; Festen S; van Grevenstein WMU; Hemmer PHJ; de Hingh IHJT; Kok NFM; Musters GD; Schoonderwoerd L; Tuynman JB; van de Ven AWH; van Westreenen HL; Wiezer MJ; Zimmerman DDE; van Zweeden AA; Dijkgraaf MGW; Tanis PJ;
    Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):761-770. PubMed ID: 31371228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic value of genetic detection using CEA and MAGE in peritoneal washes with gastric carcinoma after curative resection: result of a 3-year follow-up.
    Jeon CH; Kim IH; Chae HD
    Medicine (Baltimore); 2014 Sep; 93(11):e83. PubMed ID: 25192488
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current trends in the management of malignant peritoneal mesothelioma.
    Miura JT; Johnston FM; Gamblin TC; Turaga KK
    Ann Surg Oncol; 2014 Nov; 21(12):3947-53. PubMed ID: 24841356
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
    Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
    Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience.
    Solomon D; Bekhor E; Leigh N; Maniar YM; Totin L; Hofstedt M; Aycart SN; Carr J; Ballentine S; Magge DR; Golas BJ; Pai RK; Polydorides AD; Bartlett DL; Labow DM; Choudry HA; Sarpel U
    Ann Surg Oncol; 2020 Jan; 27(1):147-153. PubMed ID: 31385130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.